Home > Insider Trading > Filing (0001209191-18-034172)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1659323	Iterum Therapeutics Plc	ITRM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1553593	W. Michael Dunne	C/O Iterum Therapeutics Plc, Blk 2 Fl. 3, Harcourt Centre, Harcourt St. Dublin L2 2	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2018-05-30	12,730	$0.00	137,491	No	4	C	Direct
Ordinary Shares	Acquisiton	2018-05-30	4,050	$0.00	141,541	No	4	C	Direct
Ordinary Shares	Acquisiton	2018-05-30	2,917	$0.00	144,458	No	4	C	Direct
Ordinary Shares	Acquisiton	2018-05-30	2,000	$13.00	146,458	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Series A Preferred Shares	Disposition	2018-05-30	12,730	$0.00	12,730	$0.00
Ordinary Shares	Series B-1 Preferred Shares	Disposition	2018-05-30	4,050	$0.00	4,050	$0.00
Ordinary Shares	Series B-2 Preferred Shares	Disposition	2018-05-30	2,917	$0.00	2,917	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct

Footnotes

The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
Not applicable.